Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

CD4(+) T-cell subsets and host defense in the lung.

Kolls JK.

Immunol Rev. 2013 Mar;252(1):156-63. doi: 10.1111/imr.12030. Review.

2.

The mucosal immune system: primary target for HIV infection and AIDS.

Veazey RS, Marx PA, Lackner AA.

Trends Immunol. 2001 Nov;22(11):626-33. Review.

PMID:
11698224
3.

The potential impact of CD4+ T cell activation and enhanced Th1/Th2 cytokine ratio on HIV-1 secretion in the lungs of individuals with advanced AIDS and active pulmonary infection.

Rubbo PA, Tuaillon E, Bolloré K, Foulongne V, Bourdin A, Nagot N, Van de Perre P, Desgranges C, Israël-Biet D, Vendrell JP.

Clin Immunol. 2011 May;139(2):142-54. doi: 10.1016/j.clim.2011.01.007. Epub 2011 Jan 27.

PMID:
21345739
4.

[Deep lung--cellular reaction to HIV].

Tavares Marques MA, Alves V, Duque V, Botelho MF.

Rev Port Pneumol. 2007 Mar-Apr;13(2):175-212. Review. Portuguese.

PMID:
17492233
5.

CD127 and CD25 expression defines CD4+ T cell subsets that are differentially depleted during HIV infection.

Dunham RM, Cervasi B, Brenchley JM, Albrecht H, Weintrob A, Sumpter B, Engram J, Gordon S, Klatt NR, Frank I, Sodora DL, Douek DC, Paiardini M, Silvestri G.

J Immunol. 2008 Apr 15;180(8):5582-92.

6.

Role of novel type I interferon epsilon in viral infection and mucosal immunity.

Xi Y, Day SL, Jackson RJ, Ranasinghe C.

Mucosal Immunol. 2012 Nov;5(6):610-22. doi: 10.1038/mi.2012.35. Epub 2012 May 23.

7.

Mucosal immune dysfunction in AIDS pathogenesis.

Paiardini M, Frank I, Pandrea I, Apetrei C, Silvestri G.

AIDS Rev. 2008 Jan-Mar;10(1):36-46. Review.

PMID:
18385779
8.
9.

Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers of HIV disease progression.

Schechter M, Harrison LH, Halsey NA, Trade G, Santino M, Moulton LH, Quinn TC.

JAMA. 1994 Feb 2;271(5):353-7.

PMID:
7904317
10.

Pathogen-Specific T Cell Polyfunctionality Is a Correlate of T Cell Efficacy and Immune Protection.

Boyd A, Almeida JR, Darrah PA, Sauce D, Seder RA, Appay V, Gorochov G, Larsen M.

PLoS One. 2015 Jun 5;10(6):e0128714. doi: 10.1371/journal.pone.0128714. eCollection 2015. Erratum in: PLoS One. 2015;10(9):e0138395.

11.

CD4(+) T-cell subsets in intestinal inflammation.

Shale M, Schiering C, Powrie F.

Immunol Rev. 2013 Mar;252(1):164-82. doi: 10.1111/imr.12039. Review.

12.
13.

Activation-induced cell death drives profound lung CD4(+) T-cell depletion in HIV-associated chronic obstructive pulmonary disease.

Popescu I, Drummond MB, Gama L, Coon T, Merlo CA, Wise RA, Clements JE, Kirk GD, McDyer JF.

Am J Respir Crit Care Med. 2014 Oct 1;190(7):744-55. doi: 10.1164/rccm.201407-1226OC.

14.

The role of Th17 cytokines in primary mucosal immunity.

Kolls JK, Khader SA.

Cytokine Growth Factor Rev. 2010 Dec;21(6):443-8. doi: 10.1016/j.cytogfr.2010.11.002. Epub 2010 Nov 20. Review.

15.
16.

[Relationship between T-subsets and clinical aspects of HIV-associated diseases].

Fuchs M, Stadler BM, Malinverni R, de Weck AL, Pichler WJ.

Schweiz Med Wochenschr. 1991 Jan 19;121(3):57-66. German.

PMID:
1671535
17.

CD4+ T lymphocytes in lung fibrosis: diverse subsets, diverse functions.

Lo Re S, Lison D, Huaux F.

J Leukoc Biol. 2013 Apr;93(4):499-510. doi: 10.1189/jlb.0512261. Epub 2012 Nov 16. Review.

PMID:
23159927
18.
19.

Do Vgamma2Vdelta2 T cells influence HIV disease progression?

Nunnari G.

Clin Infect Dis. 2008 May 1;46(9):1473-5. doi: 10.1086/587108. No abstract available.

PMID:
18419458
20.

Apoptosis of HIV-specific CD8+ T cells: an HIV evasion strategy.

Petrovas C, Mueller YM, Katsikis PD.

Cell Death Differ. 2005 Aug;12 Suppl 1:859-70. Review. No abstract available.

Supplemental Content

Support Center